In Silico Study of Potential Cross-Kingdom Plant MicroRNA Based Regulation in Chronic Myeloid Leukemia

Author(s): Marjanu Hikmah Elias*, Noraziah Nordin, Nazefah Abdul Hamid

Journal Name: Current Pharmacogenomics and Personalized Medicine
Formerly Current Pharmacogenomics

Volume 17 , Issue 2 , 2020


Become EABM
Become Reviewer
Call for Editor

Graphical Abstract:


Abstract:

Background: Chronic Myeloid Leukaemia (CML) is associated with the BCRABL1 gene, which plays a central role in the pathogenesis of CML. Thus, it is crucial to suppress the expression of BCR-ABL1 in the treatment of CML. MicroRNA is known to be a gene expression regulator and is thus a good candidate for molecularly targeted therapy for CML.

Objective: This study aims to identify the microRNAs from edible plants targeting the 3’ Untranslated Region (3’UTR) of BCR-ABL1.

Methods: In this in silico analysis, the sequence of 3’UTR of BCR-ABL1 was obtained from Ensembl Genome Browser. PsRNATarget Analysis Server and MicroRNA Target Prediction (miRTar) Server were used to identify miRNAs that have binding conformity with 3’UTR of BCR-ABL1. The MiRBase database was used to validate the species of plants expressing the miRNAs. The RNAfold web server and RNA COMPOSER were used for secondary and tertiary structure prediction, respectively.

Results: In silico analyses revealed that cpa-miR8154, csi-miR3952, gma-miR4414-5p, mdm-miR482c, osa-miR1858a and osa-miR1858b show binding conformity with strong molecular interaction towards 3’UTR region of BCR-ABL1. However, only cpa-miR- 8154, osa-miR-1858a and osa-miR-1858b showed good target site accessibility.

Conclusion: It is predicted that these microRNAs post-transcriptionally inhibit the BCRABL1 gene and thus could be a potential molecular targeted therapy for CML. However, further studies involving in vitro, in vivo and functional analyses need to be carried out to determine the ability of these miRNAs to form the basis for targeted therapy for CML.

Keywords: BCR-ABL1, Chronic Myeloid Leukemia, MicroRNA, 3’ Untranslated Region, in silico, cross kingdom.

[1]
Maru Y. Molecular biology of chronic myeloid leukemia. Cancer Sci 2012; 103(9): 1601-10.
[http://dx.doi.org/10.1111/j.1349-7006.2012.02346.x ] [PMID: 22632137]
[2]
Yong AS, Melo JV. The impact of gene profiling in chronic myeloid leukaemia. Best Pract Res Clin Haematol 2009; 22(2): 181-90.
[http://dx.doi.org/10.1016/j.beha.2009.04.002 ] [PMID: 19698927]
[3]
Rowley JD. Ph1-positive leukaemia, including chronic myelogenous leukaemia. Clin Haematol 1980; 9(1): 55-86.
[PMID: 6245823]
[4]
Kantarjian HM, Talpaz M, Giles F, O’Brien S, Cortes J. New insights into the pathophysiology of chronic myeloid leukemia and imatinib resistance. Ann Intern Med 2006; 145(12): 913-23.
[http://dx.doi.org/10.7326/0003-4819-145-12-200612190-00008 ] [PMID: 17179059]
[5]
Druker BJ, Guilhot F, O’Brien SG, Gathmann I, Kantarjian H, Gattermann N, et al. IRIS investigators. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med 2006; 355(23): 2408-17.
[http://dx.doi.org/10.1056/NEJMoa062867 ] [PMID: 17151364]
[6]
Behbahani GD, Ghahhari NM, Javidi MA, Molan AF, Feizi N, Babashah S. MicroRNA-mediated post-transcriptional regulation of epithelial to mesenchymal transition in cancer. Pathol Oncol Res 2017; 23(1): 1-12.
[http://dx.doi.org/10.1007/s12253-016-0101-6 ] [PMID: 27590333]
[7]
Arabanian LS, Fierro FA, Stölzel F, Heder C, Poitz DM, Strasser RH, et al. MicroRNA-23a mediates post-transcriptional regulation of CXCL12 in bone marrow stromal cells. Haematologica 2014; 99(6): 997-1005.
[http://dx.doi.org/10.3324/haematol.2013.097675 ] [PMID: 24584347]
[8]
Jonas S, Izaurralde E. Towards a molecular understanding of microRNA-mediated gene silencing. Nat Rev Genet 2015; 16(7): 421-33.
[http://dx.doi.org/10.1038/nrg3965 ] [PMID: 26077373]
[9]
Lukasik A, Zielenkiewicz P. Plant microRNAs-novel players in natural medicine? Int J Mol Sci 2016; 18(1): E9
[http://dx.doi.org/10.3390/ijms18010009] [PMID: 28025496]
[10]
Liu YC, Chen WL, Kung WH, Huang HD. Plant miRNAs found in human circulating system provide evidences of cross kingdom RNAi. BMC Genomics 2017; 18(Suppl. 2): 112.
[http://dx.doi.org/10.1186/s12864-017-3502-3 ] [PMID: 28361700]
[11]
Zhang H, Li Y, Liu Y, Liu H, Wang H, Jin W, et al. Role of plant MicroRNA in cross-species regulatory networks of humans. BMC Syst Biol 2016; 10(1): 60.
[http://dx.doi.org/10.1186/s12918-016-0292-1 ] [PMID: 27502923]
[12]
Chin AR, Fong MY, Somlo G, Wu J, Swiderski P, Wu X, et al. Cross-kingdom inhibition of breast cancer growth by plant miR159. Cell Res 2016; 26(2): 217-28.
[http://dx.doi.org/10.1038/cr.2016.13 ] [PMID: 26794868]
[13]
Ge Q, Zhou Y, Lu J, Bai Y, Xie X, Lu Z. MiRNA in plasma exosome is stable under different storage conditions. Molecules 2014; 19(2): 1568-75.
[http://dx.doi.org/10.3390/molecules19021568 ] [PMID: 24473213]
[14]
Philip A, Ferro VA, Tate RJ. Determination of the potential bioavailability of plant microRNAs using a simulated human digestion process. Mol Nutr Food Res 2015; 59(10): 1962-72.
[http://dx.doi.org/10.1002/mnfr.201500137 ] [PMID: 26147655]
[15]
Zerbino DR, Achuthan P, Akanni W, Amode MR, Barrell D, Bhai J, et al. Ensembl 2018. Nucleic Acids Res 2018; 46(D1): D754-61.
[http://dx.doi.org/10.1093/nar/gkx1098 ] [PMID: 29155950]
[16]
Dai X, Zhuang Z, Zhao PX. psRNATarget: A plant small RNA target analysis server (2017 release). Nucleic Acids Res 2018; 46(W1): W49-54
[http://dx.doi.org/10.1093/nar/gky316 ] [PMID: 29718424]
[17]
Kozomara A, Birgaoanu M, Griffiths-Jones S. miRBase: From microRNA sequences to function. Nucleic Acids Res 2019; 47(D1): D155-62.
[http://dx.doi.org/10.1093/nar/gky1141 ] [PMID: 30423142]
[18]
Hsu JBK, Chiu CM, Hsu SD, Huang WY, Chien CH, Lee TY, et al. miRTar: An integrated system for identifying miRNA-target interactions in human. BMC Bioinformatics 2011; 12: 300.
[http://dx.doi.org/10.1186/1471-2105-12-300 ] [PMID: 21791068]
[19]
Lorenz R, Bernhart SH, Höner Zu Siederdissen C, Tafer H, Flamm C, Stadler PF, et al. ViennaRNA Package 2.0. Algorithms Mol Biol 2011; 6: 26.
[http://dx.doi.org/10.1186/1748-7188-6-26 ] [PMID: 22115189]
[20]
Biesiada M, Purzycka KJ, Szachniuk M, Blazewicz J, Adamiak RW. Automated RNA 3D structure prediction with RNAComposer. Methods Mol Biol 2016; 1490: 199-215.
[http://dx.doi.org/10.1007/978-1-4939-6433-8_13 ] [PMID: 27665601]
[21]
Li Y, Yuan Y, Tao K, Wang X, Xiao Q, Huang Z, et al. Inhibition of BCR/ABL protein expression by miR-203 sensitizes for imatinib mesylate. PLoS One 2013; 8(4): e61858
[http://dx.doi.org/10.1371/journal.pone.0061858] [PMID: 23613955]
[22]
Xishan Z, Ziying L, Jing D, Gang L. MicroRNA-320a acts as a tumor suppressor by targeting BCR/ABL oncogene in chronic myeloid leukemia. Sci Rep 2015; 5: 12460.
[http://dx.doi.org/10.1038/srep12460 ] [PMID: 26228085]
[23]
Iraci N, Valli E, Gherardi S, Soverini S, Kalebic T, Baccarani M, et al. Suppression of Bcr-Abl Expression in CML by A Panel of miRNAs. Blood 2009; 114(22): 854.
[http://dx.doi.org/10.1182/blood.V114.22.854.854]
[24]
Reneker J, Lyons E, Conant GC, Pires JC, Freeling M, Shyu CR, et al. Long identical multispecies elements in plant and animal genomes. Proc Natl Acad Sci USA 2012; 109(19): E1183-91.
[http://dx.doi.org/10.1073/pnas.1121356109 ] [PMID: 22496592]
[25]
Lee CT, Risom T, Strauss WM. Evolutionary conservation of microRNA regulatory circuits: An examination of microRNA gene complexity and conserved microRNA-target interactions through metazoan phylogeny. DNA Cell Biol 2007; 26(4): 209-18.
[http://dx.doi.org/10.1089/dna.2006.0545 ] [PMID: 17465887]
[26]
Marín RM, Vanícek J. Efficient use of accessibility in microRNA target prediction. Nucleic Acids Res 2011; 39(1): 19-29.
[http://dx.doi.org/10.1093/nar/gkq768 ] [PMID: 20805242]
[27]
Nakano M, Nobuta K, Vemaraju K, Tej SS, Skogen JW, Meyers BC. Plant MPSS databases: Signature-based transcriptional resources for analyses of mRNA and small RNA. Nucleic Acids Res 2006; 34(Database issue): D731-5.
[http://dx.doi.org/10.1093/nar/gkj077 ] [PMID: 16381968]
[28]
Wang W, Liu D, Zhang X, Chen D, Cheng Y, Shen F. Plant microRNAs in cross-kingdom regulation of gene expression. Int J Mol Sci 2018; 19(7): E2007
[http://dx.doi.org/10.3390/ijms19072007] [PMID: 29996470]
[29]
Zhang L, Hou D, Chen X, Li D, Zhu L, Zhang Y, et al. Exogenous plant MIR168a specifically targets mammalian LDLRAP1: Evidence of cross-kingdom regulation by microRNA. Cell Res 2012; 22(1): 107-26.
[http://dx.doi.org/10.1038/cr.2011.158 ] [PMID: 21931358 ]


Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 17
ISSUE: 2
Year: 2020
Page: [125 - 132]
Pages: 8
DOI: 10.2174/1875692118666200106113610
Price: $25

Article Metrics

PDF: 13
HTML: 2